Segments (Tables)

9 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	For the Three Months Ended				For the Nine Months Ended
	March 31,				March 31,
	2016		2015		2016		2015
Net Sales
North America	$	193,866	$	204,671	$	610,843	$	542,141
Europe		184,492		192,096		606,876		637,285
Asia		20,826		19,440		69,873		35,690
Total Net Sales	$	399,184	$	416,207	$	1,287,592	$	1,215,116
Depreciation and Amortization
North America	$	15,258	$	16,074	$	45,462	$	45,809
Europe		15,261		15,440		49,000		50,506
Asia		933		891		3,028		1,670
Total Depreciation and Amortization	$	31,452	$	32,405	$	97,490	$	97,985
Operating Income
North America	$	11,945	$	6,551	$	21,242	$	17,888
Europe		12,303		11,785		42,846		42,176
Asia		1,765		494		9,727		1,430
Total Operating Income	$	26,013	$	18,830	$	73,815	$	61,494
Adjusted EBITDA *
North America	$	26,581	$	26,013	$	88,382	$	73,220
Europe		29,063		28,897		103,423		99,566
Asia		2,707		2,408		13,148		4,162
Total Adjusted EBITDA	$	58,351	$	57,318	$	204,953	$	176,948

* To supplement our financial information presented in accordance with GAAP, the Company uses EBITDA and Adjusted EBITDA (non-GAAP financial measures) to clarify and enhance an understanding of past performance.  The Company believes that the presentation of these financial measures enhances an investor’s understanding of our financial performance and that these financial measures are useful financial metrics to assess our operating performance from period to period by excluding certain items that we believe are not representative of our core business.  The Company also believes that these financial measures provide investors with a useful tool for assessing the comparability between periods of the ability to generate cash from operations sufficient to pay taxes, to service debt and to undertake capital expenditures.  These financial measures are used for business planning purposes and in measuring performance relative to that of competitors and the Company believe these financial measures are commonly used by investors.  However, our use of the terms EBITDA and Adjusted EBITDA may vary from that of others in the industry.  A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is presented further below.

MPSX_CapitalExpenditureBySegment [Table Text Block]

	For the Nine Months Ended
	March 31,
	2016		2015
Capital Expenditures
North America	$	12,867	$	13,436
Europe		18,846		22,976
Asia		5,006		1,266
Total Capital Expenditures	$	36,719	$	37,678

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	As of March 31,		As of June 30,
	2016		2015
Total Assets
North America	$	787,224	$	915,601
Europe		931,467		866,214
Asia		68,697		100,310
Total Assets	$	1,787,388	$	1,882,125

Revenue from External Customers by Products and Services [Table Text Block]

	For the Three Months Ended				For the Nine Months Ended
	March 31,				March 31,
	2016		2015		2016		2015
Premium Folding Cartons	$	257,827	$	260,285	$	842,704	$	781,171
Inserts		56,274		81,003		183,361		202,527
Labels		36,216		27,689		101,865		95,316
Rigid Packaging		23,181		23,485		89,104		45,072
Other Consumer Products		57,576		57,291		167,716		170,678
Total		431,074		449,753		1,384,750		1,294,764
Sales Reserves and Eliminations		(31,890)		(33,546)		(97,158)		(79,648)
Total Net Sales	$	399,184	$	416,207	$	1,287,592	$	1,215,116
Net Sales by category
Consumer	$	199,578	$	204,990	$	659,664	$	609,393
Healthcare		166,791		176,469		474,604		485,528
Multi-Media		32,815		34,748		153,324		120,195
Total Net Sales	$	399,184	$	416,207	$	1,287,592	$	1,215,116

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

	For the Three Months Ended				For the Nine Months Ended
	March 31,				March 31,
	2016		2015		2016		2015
Consolidated net income	$	3,613	$	6,990	$	8,693	$	11,883
Depreciation and amortization		31,452		32,405		97,490		97,985
Interest expense		14,896		17,631		49,641		54,042
Income tax expense		6,178		3,309		6,753		6,212
EBITDA		56,139		60,335		162,577		170,122
Transaction costs		371		1,914		2,785		6,098
Stock based and deferred compensation		104		517		27,064		1,403
Debt extinguishment charges		64		—		3,931		—
Purchase accounting adjustments		255		1,171		878		2,024
Restructuring related costs		693		1,700		4,269		5,490
Loss on sale of fixed assets		236		237		598		645
Foreign currency (gains) losses		510		(9,259)		3,850		(13,835)
Other adjustments to EBITDA		(21)		703		(999)		5,001
Adjusted EBITDA	$	58,351	$	57,318	$	204,953	$	176,948